PAPER Salvador GA, Oteiza PI
SEARCH RESULTS
331159 RESULTS
PAPER Micheau J, Marighetto A
Acetylcholine and memory: a long, complex and chaotic but still living relationship.
Behav Brain Res. 2011 Aug 10;221(2):424-9. PubMed: 21130809PAPER Jhala SS, Hazell AS
Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism.
Neurochem Int. 2011 Feb;58(3):248-60. PubMed: 21130821PAPER Choi JS, Braymer JJ, Nanga RP, Ramamoorthy A, Lim MH
Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.
Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):21990-5. PubMed: 21131570PAPER Grossberg GT, Schmitt FA, Meng X, Tekin S, Olin J
Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):627-33. PubMed: 21131668PAPER Kang S, Gearhart S, Bae HS
Coverage of Alzheimer's disease from 1984 to 2008 in television news and information talk shows in the United States: an analysis of news framing.
Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):687-97. PubMed: 21131676PAPER Belbin O, Carrasquillo MM, Crump M, Culley OJ, Hunter TA, Ma L, Bisceglio G, Zou F, Allen M, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG
Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease.
Hum Genet. 2011 Mar;129(3):273-82. PubMed: 21132329PAPER Benedict KF, Mac Gabhann F, Amanfu RK, Chavali AK, Gianchandani EP, Glaw LS, Oberhardt MA, Thorne BC, Yang JH, Papin JA, Peirce SM, Saucerman JJ, Skalak TC
Systems analysis of small signaling modules relevant to eight human diseases.
Ann Biomed Eng. 2011 Feb;39(2):621-35. PubMed: 21132372PAPER Shen D, Coleman J, Chan E, Nicholson TP, Dai L, Sheppard PW, Patton WF
Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies.
Cell Biochem Biophys. 2011 Jul;60(3):173-85. PubMed: 21132543PAPER Jacobs HI, van Boxtel MP, Uylings HB, Gronenschild EH, Verhey FR, Jolles J
Atrophy of the parietal lobe in preclinical dementia.
Brain Cogn. 2011 Mar;75(2):154-63. PubMed: 21130554PAPER Mourtas S, Canovi M, Zona C, Aurilia D, Niarakis A, La Ferla B, Salmona M, Nicotra F, Gobbi M, Antimisiaris SG
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide.
Biomaterials. 2011 Feb;32(6):1635-45. PubMed: 21131044PAPER Sultan A, Nesslany F, Violet M, Bégard S, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buée L, Galas MC
Nuclear tau, a key player in neuronal DNA protection.
J Biol Chem. 2011 Feb 11;286(6):4566-75. PubMed: 21131359PAPER Prins ND, van Swieten JC
Alzheimer disease: MRI and CSF biomarkers in AD--accuracy and temporal change.
Nat Rev Neurol. 2010 Dec;6(12):650-1. PubMed: 21131912David Gillam on Focus on the Locus! (Ceruleus, That Is, in Alzheimer’s Disease)
COMMENT Any new drugs that affect amyloid in the brain? davidgillam 0
Lary Walker on San Diego: TDP-43 Targets Loom Large—But Where’s the Bull’s Eye?
COMMENT Two prominent messages emerge from the Sephton paper and the burgeoning literature on TDP-43: 1) TDP-43 is important for the normal functioning of cells; and 2) its actions are many and complex. This being so, is it realistic to assume that targeting one
Current Filters
No filters selected